jueves, 15 de diciembre de 2022

Failure to Respond to an ANDA Complete Response Letter Within the Regulatory Timeframe Guidance for Industry | FDA

Failure to Respond to an ANDA Complete Response Letter Within the Regulatory Timeframe Guidance for Industry | FDA

No hay comentarios: